Apimeds Pharmaceuticals US, Inc (APUS) Stock Price History
Historical prices from 2025 to 2026
Loading 10-year price history...
APUS Historical Performance
Short-Term Returns
APUS Stock Price Trajectory (2025–2026)
As of May 8, 2026, Apimeds Pharmaceuticals US, Inc (APUS) trades at $1.47, representing a -33.2% return over the past year. The stock has delivered a -33.2% total return over five years (-7.7% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $5.97 on May 5, 2026. From this peak, APUS has corrected -75.4%, currently trading 22% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers HALO (-7.1% 1Y), ACRS (+288.8% 1Y), and SLRX (-93.1% 1Y), APUS has underperformed the peer group average. Compare APUS vs HALO →
APUS Historical Price Data (2025–2026)
Showing 30 of 241 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.92 | 1.94 | 1.40 | 1.47 | 560K | -24.62% |
| 2026-05-06 | 2.14 | 2.34 | 1.95 | 1.95 | 760K | -35.00% |
| 2026-05-05 | 1.90 | 5.97 | 1.90 | 3.00 | 4.20M | +59.57% |
| 2026-04-20 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-17 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-16 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-15 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-14 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-13 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-10 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-09 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-08 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-07 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-06 | 1.88 | 1.88 | 1.88 | 1.88 | 32K | 0.00% |
| 2026-04-02 | 1.69 | 1.89 | 1.69 | 1.88 | 32K | +7.43% |
| 2026-04-01 | 1.79 | 1.82 | 1.67 | 1.75 | 25K | -2.23% |
| 2026-03-31 | 1.83 | 1.88 | 1.76 | 1.79 | 13K | +2.29% |
| 2026-03-30 | 1.88 | 1.88 | 1.71 | 1.75 | 32K | -8.38% |
| 2026-03-27 | 1.64 | 1.91 | 1.62 | 1.91 | 130K | +17.18% |
| 2026-03-26 | 1.80 | 1.91 | 1.61 | 1.63 | 170K | -6.86% |
| 2026-03-25 | 1.74 | 1.79 | 1.64 | 1.75 | 62K | +2.34% |
| 2026-03-24 | 1.89 | 1.89 | 1.60 | 1.71 | 146K | -12.31% |
| 2026-03-23 | 2.06 | 2.06 | 1.70 | 1.95 | 133K | -5.34% |
| 2026-03-20 | 1.98 | 2.10 | 1.79 | 2.06 | 274K | +5.64% |
| 2026-03-19 | 1.68 | 1.98 | 1.60 | 1.95 | 116K | +14.04% |
| 2026-03-18 | 1.63 | 1.79 | 1.51 | 1.71 | 117K | +3.01% |
| 2026-03-17 | 1.61 | 1.82 | 1.49 | 1.66 | 233K | +1.22% |
| 2026-03-16 | 1.66 | 1.78 | 1.43 | 1.64 | 301K | +1.23% |
| 2026-03-13 | 1.48 | 1.63 | 1.42 | 1.62 | 125K | +14.89% |
| 2026-03-12 | 1.39 | 1.68 | 1.37 | 1.41 | 209K | +5.22% |
See APUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs APUS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare APUS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAPUS — Frequently Asked Questions
Quick answers to the most common questions about buying APUS stock.
How has APUS stock performed recently?
APUS declined -33.2% over the past year, below its 5-year annualized CAGR of -7.7%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is APUS's all-time high price?
Apimeds Pharmaceuticals US, Inc reached $5.97 on 2026-05-05. The 52-week high is $5.97. Current 1-year return of -33.2% places the stock further from historical peaks.
Where can I download APUS historical price data?
This page provides APUS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2025-2026, downloadable in CSV format.